CLLS
Price
$2.67
Change
-$0.04 (-1.48%)
Updated
Aug 7, 04:58 PM (EDT)
Capitalization
268.32M
95 days until earnings call
PMVP
Price
$1.45
Change
-$0.07 (-4.61%)
Updated
Aug 7, 04:58 PM (EDT)
Capitalization
75.33M
Earnings call today
Interact to see
Advertisement

CLLS vs PMVP

Header iconCLLS vs PMVP Comparison
Open Charts CLLS vs PMVPBanner chart's image
Cellectis SA
Price$2.67
Change-$0.04 (-1.48%)
Volume$1.05K
Capitalization268.32M
PMV Pharmaceuticals
Price$1.45
Change-$0.07 (-4.61%)
Volume$434
Capitalization75.33M
CLLS vs PMVP Comparison Chart in %
Loading...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLLS vs. PMVP commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a Hold and PMVP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (CLLS: $2.71 vs. PMVP: $1.52)
Brand notoriety: CLLS and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 88% vs. PMVP: 56%
Market capitalization -- CLLS: $270.76M vs. PMVP: $75.33M
CLLS [@Biotechnology] is valued at $270.76M. PMVP’s [@Biotechnology] market capitalization is $75.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • CLLS’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLLS and PMVP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 4 TA indicator(s) are bullish while PMVP’s TA Score has 4 bullish TA indicator(s).

  • CLLS’s TA Score: 4 bullish, 4 bearish.
  • PMVP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CLLS and PMVP are a good buy in the short-term.

Price Growth

CLLS (@Biotechnology) experienced а +1.50% price change this week, while PMVP (@Biotechnology) price change was +7.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.15%. For the same industry, the average monthly price growth was +8.44%, and the average quarterly price growth was +12.41%.

Reported Earning Dates

CLLS is expected to report earnings on Nov 10, 2025.

PMVP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($268M) has a higher market cap than PMVP($75.3M). CLLS YTD gains are higher at: 50.556 vs. PMVP (0.662). CLLS has higher annual earnings (EBITDA): -32.49M vs. PMVP (-87.97M). CLLS has more cash in the bank: 242M vs. PMVP (160M). PMVP has less debt than CLLS: PMVP (1.11M) vs CLLS (91.8M). CLLS has higher revenues than PMVP: CLLS (47.6M) vs PMVP (0).
CLLSPMVPCLLS / PMVP
Capitalization268M75.3M356%
EBITDA-32.49M-87.97M37%
Gain YTD50.5560.6627,634%
P/E RatioN/AN/A-
Revenue47.6M0-
Total Cash242M160M151%
Total Debt91.8M1.11M8,300%
FUNDAMENTALS RATINGS
CLLS: Fundamental Ratings
CLLS
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLLSPMVP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ECTM0.600.02
+4.33%
ECA Marcellus Trust I
IQEPF0.15N/A
N/A
IQE Plc
THYCF25.00N/A
N/A
Taiheiyo Cement Corp.
FNMAI13.14N/A
N/A
Fannie Mae
DNOPF12.50N/A
N/A
DINO POLSKA SA

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been closely correlated with CMVLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLLS jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
+7.11%
CMVLF - CLLS
82%
Closely correlated
N/A
ABCZF - CLLS
58%
Loosely correlated
N/A
SLN - CLLS
43%
Loosely correlated
-5.17%
MDGL - CLLS
40%
Loosely correlated
-0.24%
PMVP - CLLS
38%
Loosely correlated
+2.70%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+2.70%
CLLS - PMVP
39%
Loosely correlated
+7.11%
LRMR - PMVP
35%
Loosely correlated
+0.80%
MTVA - PMVP
35%
Loosely correlated
+2.92%
CMVLF - PMVP
34%
Loosely correlated
N/A
TERN - PMVP
34%
Loosely correlated
-6.74%
More